Is your baby at risk for infantile hemangiomas?
Eton Pharmaceuticals has relaunched HEMANGEOL, the only FDA-approved treatment for infantile hemangiomas, with support programs to help families access care quickly.
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 1873–1896 of 3,538
Eton Pharmaceuticals has relaunched HEMANGEOL, the only FDA-approved treatment for infantile hemangiomas, with support programs to help families access care quickly.
Transplanting gut bacteria from young to old mice may lower liver cancer risk and reduce inflammation.
Oxidative stress may impair brain enzymes that help maintain protein quality, affecting cognitive health as we age.
The wound cleanser market is growing, offering better options for wound care, especially for chronic wounds in older adults.
A new DNA-based treatment could lower bad cholesterol by nearly 50% without statin side effects, offering hope for heart health.
Researchers are developing non-invasive treatments for diabetic macular edema, which could improve vision for millions affected by diabetes.
BioCardia's Heart3D software may enhance heart therapy precision, improving recovery.
A new inhaled drug for lung diseases is entering clinical trials in China.
A study shows that high-tech hydration efforts didn't effectively prevent kidney stones, emphasizing the need for personalized hydration strategies.
Alector has stopped a trial for an Alzheimer’s drug that wasn’t likely to work, but other treatments are still in development.
Stealth Biotherapeutics updates on FORZINITY, a treatment for Barth syndrome, with plans to expand access for younger patients.
A new drug tested for heart surgery complications didn't show clear benefits, but may help higher-risk patients.
Stress and late-night eating can worsen gut issues and reduce beneficial bacteria.
Cannabis leaves contain rare compounds that may offer health benefits.
A protein called HSL plays a crucial role in maintaining healthy fat tissue, impacting obesity and metabolic health.
The ANA warns that new loan rules could reduce nursing education and impact healthcare access.
A new drug, TOS-358, shows promise for treating breast cancer mutations.
A new imaging agent for gliomas may enhance diagnosis and treatment decisions for brain cancer patients.
A new resource helps grieving employees navigate work challenges after loss.
Intermountain Health's assessment highlights key health needs in Nevada, focusing on mental health and childhood safety.
A new antibody for allergies shows promise, potentially requiring less frequent dosing.
A new physical therapy clinic in Garden Grove offers personalized care to help you recover from injuries and improve mobility.
AI software EchoSolv AS is now helping doctors better diagnose heart conditions at Mount Sinai.
A new treatment may boost frataxin levels in Friedreich’s ataxia, potentially improving health outcomes.